블로그

• [공유] Inovio surges as Oppenheimer cites differentiated vaccine platform 플랫폼도 관심 가져야함 The thesis mainly highlights Inovio’s COVID-19 vaccine candidate INO-4800 which secured FDA clearance in November to start Phase 2 part of its planned Phase 2/3 (INNOVATE) trial. blog.naver.com · 2021.02.15